Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.56%
#2 Luxxcoin Luxxcoin +46.85%
#3 Layer3 Layer3 +32.82%
#4 ResearchCoin ResearchCoin +31.78%
#5 Reactive Network Reactive Network +24.01%
#6 Orderly Network Orderly Network +17.27%
#7 Bitgert Bitgert +17.01%
#8 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +10.20%
#9 Useless Coin Useless Coin +10.11%
#10 OpenVPP OpenVPP +9.68%
Coin of the day
Resolv wstUSR Resolv wstUSR
Settings
Language
ENGLISH
Currency
USD
Theme
CSL Limited CSL Limited

CSL Limited

CSL
Rank in Stocks #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Share Price
$99.32
Market Cap
$48.20B
Change (1 day)
0.98%
Change (1 year)
-32.14%
Country
AU
Trade CSL Limited (CSL)

Category

Healthcare
Stock price history for CSL Limited (CSL)
Highest end of day price: $99.95 on 2026-03-01

Lowest end of day price: $0.55 on 1994-05-01
Stock price history of CSL Limited from 1994 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 13.01%
2025 -33.08%
2024 -3.77%
2023 -7.04%
2022 -5.69%
2021 -4.35%
2020 13.64%
2019 48.92%
2018 19.64%
2017 51.86%
2016 -2.99%
2015 3.42%
2014 17.66%
2013 7.48%
2012 72.85%
2011 -9.62%
2010 27.38%
2009 31.88%
2008 -30.73%
2007 91.49%
2006 59.38%
2005 39.53%
2004 69.70%
2003 11.09%
2002 -54.53%
2001 23.70%
2000 43.48%
1999 74.26%
1998 29.88%
1997 51.86%
1996 75.17%
1995 46.22%
1994 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $35.14 -42.95%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $440.41 -6.77%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $749.56 34.62%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $300.57 84.76%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $700.87 27.68%
NL